TY  - GEN
AU  - Kumar,B N Prashanth
AU  - Puvvada,Nagaprasad
AU  - Rajput,Shashi
AU  - Sarkar,Siddik
AU  - Mahto,Madhusudan Kr
AU  - Yallapu,Murali M
AU  - Pathak,Amita
AU  - Emdad,Luni
AU  - Das,Swadesh K
AU  - Reis,Rui L
AU  - Kundu,S C
AU  - Fisher,Paul B
AU  - Mandal,Mahitosh
TI  - Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer
SN  - 1543-8392
PY  - 2019///0624
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Catechin
KW  - analogs & derivatives
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Chemical Engineering
KW  - Drug Carriers
KW  - chemistry
KW  - Drug Resistance, Neoplasm
KW  - ErbB Receptors
KW  - metabolism
KW  - Female
KW  - Gold
KW  - Humans
KW  - Metal Nanoparticles
KW  - Mice, Nude
KW  - Piperidines
KW  - Porosity
KW  - Proto-Oncogene Proteins c-akt
KW  - Quinazolines
KW  - Silicon Dioxide
KW  - Tamoxifen
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor Receptor-2
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1021/acs.molpharmaceut.8b00218
ER  -